Tectonic Therapeutic
Othman Benchama has worked in the scientific field since 2007. Othman began their career as an Intern/Research Assistant at the Boston University School of Medicine. Othman then moved to Cambridge Biomedical as a Research Assistant in 2010. In 2012, they joined the Center for Drug Discovery at Northeastern University, where they held the roles of Postdoctoral Researcher, PhD Candidate, and Senior Research Associate. In 2021, they accepted a position as Target Validation Scientist at Generate Biomedicines. Currently, they are working as a Scientist - Cell Pharmacology at Tectonic Therapeutic, Inc.
Othman Benchama obtained a Bachelor's degree in Biotechnology from Boston University.
Tectonic Therapeutic
5 followers
Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs).